Oramed Pharmaceuticals (ORMP -0.7%) says it's been in talks with the FDA regarding its...

|By:, SA News Editor

Oramed Pharmaceuticals (ORMP -0.7%) says it's been in talks with the FDA regarding its Investigational New Drug application for oral insulin. The FDA has asked Oramed to perform a sub study in a controlled in-patient setting for up to a one-week period. Oramed will submit a new IND with a clinical protocol for the study.